复方磺胺甲噁唑预防用药在疟疾子孢子免疫中诱导长效保护
该研究利用啮齿动物疟疾模型,探讨在给予预防剂量复方磺胺甲噁唑(TMP-SMX)期间反复暴露于疟疾寄生虫是否能诱导针对子孢子攻击的长效保护性免疫。结果表明,TMP-SMX给药期间反复暴露可诱导阶段特异性的长效红细胞前期保护性抗疟免疫,主要由CD8+ T细胞介导。作者提示HIV感染或暴露儿童的TMP-SMX预防疗程设计需考虑其潜在抗感染免疫效应。
要点
- TMP-SMX预防期间反复疟疾暴露可诱导长效红细胞前期保护性免疫。
- 该保护性免疫主要由CD8+ T细胞介导。
- HIV高流行区儿童TMP-SMX预防疗程研究需考虑免疫效应。
核心结论
- 在啮齿动物疟疾模型中,TMP-SMX预防期间反复暴露于疟原虫可诱导阶段特异且长效的红细胞前期保护性抗疟免疫。
研究设计与样本
- 研究采用啮齿动物疟疾模型,基于既往发现TMP-SMX预防剂量可阻滞疟原虫肝期发育的結果进一步验证。
主要发现
- 反复暴露于疟疾寄生虫期间给予TMP-SMX可诱导针对红细胞前期的长效保护性免疫。
- 该保护性免疫主要由CD8+ T细胞介导。
临床怎么用
- 在HIV感染或HIV暴露儿童中设计TMP-SMX预防疗程的临床研究时,需考虑TMP-SMX预防可能诱导的抗感染免疫效应。
局限性
- 研究基于啮齿动物疟疾模型,结论外推至人类儿童需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Trimethoprim-sulfamethoxazole (TMP-SMX) is widely used in malaria-endemic areas in human immunodeficiency virus (HIV)-infected children and HIV-uninfected, HIV-exposed children as opportunistic infection prophylaxis. Despite the known effects that TMP-SMX has in reducing clinical malaria, its impact on development of malaria-specific immunity in these children remains poorly understood. Using rodent malaria models, we previously showed that TMP-SMX, at prophylactic doses, can arrest liver stage development of malaria parasites and speculated that TMP-SMX prophylaxis during repeated malaria exposures would induce protective long-lived sterile immunity targeting pre-erythrocytic stage parasites in mice. Using the same models, we now demonstrate that repeated exposures to malaria parasites during TMP-SMX administration induces stage-specific and long-lived pre-erythrocytic protective anti-malarial immunity, mediated primarily by CD8+ T-cells. Given the HIV infection and malaria coepidemic in sub-Saharan Africa, clinical studies aimed at determining the optimum duration of TMP-SMX prophylaxis in HIV-infected or HIV-exposed children must account for the potential anti-infection immunity effect of TMP-SMX prophylaxis.
引用
- Hobbs CV, Anderson C, Neal J, et al. Trimethoprim-Sulfamethoxazole Prophylaxis During Live Malaria Sporozoite Immunization Induces Long-Lived, Homologous, and Heterologous Protective Immunity Against Sporozoite Challenge. J Infect Dis. 2016. PMID: 28077589. doi:10.1093/infdis/jiw482
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。